WASHINGTON — Justin Gover joined GW Pharmaceuticals, a company laser-focused on creating cannabinoid-based medicines, back in 1999, a time when the acronym CBD meant virtually nothing to most Americans, and more than two-thirds of Americans opposed the legalization of marijuana.
Fast forward 20 years and GW is in the middle of a CBD boom.
About the Author Reprints
There is no magic pill in the world, it wastes the time and resources.